BeiGene USA, Inc

Enzyvant Therapeutics Inc, based in Cambridge, MA, is a pioneering company dedicated to improving global health and well-being. With a focus on critical areas such as psychiatry, neurology, oncology, urology, women's health, rare diseases, and cell gene therapy, they drive innovation in treatments, science, and technology to address patient needs. Enzyvant's diverse pipeline of preclinical and clinical programs spans various modalities and indications, aiming to meet high or unmet patient needs. Through their technology-driven approach, they strive to deliver breakthrough solutions that prioritize patient outcomes, making a measurable impact on healthcare.Generated from the website

Sage Therapeutics, Inc., based in Cambridge, MA, is focused on rethinking the delivery of care for patients and families affected by brain health disorders. Through innovative research programs and a commitment to patient advocacy, the company aims to transform the understanding and treatment of neurological conditions. In collaboration with partners like Shionogi Co. Ltd., Sage is advancing its clinical pipeline, including investigational treatments such as zuranolone. The company emphasizes safety and efficacy in its research, continually striving to improve outcomes for those impacted by brain health issues. Generated from the website

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.